STAT+: Amgen spends $1.9 billion on Five Prime, eyeing an expansion in Asia
Amgen said it will purchase Five Prime Therapeutics for $1.9 billion to obtain a potential treatment for gastric cancer, a move that will also expand the biotech giant’s focus in…
